Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

58
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
58
Dialysis01:27

Dialysis

272
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
272
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

1
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

346
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
346

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

High-Resolution Modeling of Wet Bulb Globe Temperature Reveals Substantial Heat Risks Across Crops and Work Shifts Among Agricultural Workers in Southern California.

GeoHealth·2026
Same author

Mind the Gap: eGFR Discordancy and Melphalan Toxicity in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant.

Kidney360·2026
Same author

High-salt and high-sucrose diets may not reliably induce hypertension or diabetes in rat models.

Scientific reports·2026
Same author

A 32-year species-specific live fuel moisture content dataset for southern California chaparral.

Scientific data·2026
Same author

Concordance of Prebiopsy and Postbiopsy Diagnosis in Hospitalized Patients with Acute Kidney Injury.

Kidney360·2026
Same author

Development of Urinalysis Screening Criteria for Rhabdomyolysis in Acute Kidney Injury.

Kidney360·2026

相关实验视频

Updated: Jun 9, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K

对于急性损伤住院患者的早期个性化建议:一项随机临床试验

Abinet M Aklilu1,2, Steven Menez3, Megan L Baker2

  • 1Clinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.

JAMA
|October 25, 2024
PubMed
概括

行动小组的建议并没有显著改善急性损伤 (AKI) 的住院患者的治疗结果. 虽然实施率较高,但AKI进展,透析或死亡率的综合结果保持不变.

更多相关视频

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.1K
Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock
07:48

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock

Published on: October 28, 2022

1.1K

相关实验视频

Last Updated: Jun 9, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K
Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.1K
Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock
07:48

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock

Published on: October 28, 2022

1.1K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 医院 医院 医疗 医疗 医疗 医疗
  • 临床信息学 临床信息学

背景情况:

  • 急性损伤 (AKI) 是住院患者的常见和严重并发症,经常导致不良健康事件.
  • 早期检测和干预对于管理AKI至关重要,但最佳策略仍在调查中.

研究的目的:

  • 确定通过电子健康记录 (EHR) 提供的行动小组 (KAT) 的诊断和治疗建议是否改善了与标准护理相比,AKI住院患者的治疗结果.
  • 评估KAT干预对AKI进展,透析和死亡率的影响.

主要方法:

  • 一项随机临床试验,涉及4003名在美国7家医院的AKI住院患者.
  • 患者被随机分配,通过EHR从KAT获得建议,或接受通常的护理.
  • 在AKI检测后1小时内,KAT提供了个性化的建议,包括诊断,流体管理,电解质,酸平衡和药物.

主要成果:

  • 主要综合结局 (AKI进展,透析或14天内住院死亡率) 发生在干预组的19.8%和通常护理组的18.4% (P=.28).
  • 在干预组中,KAT建议的实施率明显高 (33.8%),相比于常规护理组 (24.3%).
  • 在干预组和通常护理组之间的初级复合结果中没有发现显著差异.

结论:

  • 尽管建议的执行率更高,但脏行动小组的干预措施并没有显著减少住院患者恶化的AKI,透析或死亡的复合结果.
  • 可能需要进一步的研究来优化KAT干预措施或探索替代策略,以改善AKI在医院环境中的结果.